Inventor · disambiguated record
John Vasilakos
Also filed as: VASILAKOS JOHN · VASILAKOS JOHN P
8 granted patents·15 pending applications·535 citations·filing 1999–2021
87Inventor score
Top patents by PatentIndex Score
23 records- 0197US6558951B1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 1999·Granted May 6, 2003·342 cites·10 claims
- 0294US7375180B2Methods and compositions related to IRM compounds and Toll-like receptor 83M INNOVATIVE PROPERTIES CO·Filed 2004·Granted May 20, 2008·121 cites·17 claims
- 0390US7485432B2Selective modulation of TLR-mediated biological activity3M INNOVATIVE PROPERTIES CO·Filed 2004·Granted Feb 3, 2009·65 cites·9 claims
- 0484US9980956B2Methods and therapeutic combinations for treating tumors3M INNOVATIVE PROPERTIES CO·Filed 2015·Granted May 29, 2018·3 cites·30 claims
- 0579US9943607B2Beta-glucan compounds, compositions, and methodsBOSE NANDITA·Filed 2012·Granted Apr 17, 2018·3 cites·22 claims
- 0675US10583134B2Methods and therapeutic combinations for treating tumors3M INNOVATIVE PROPERTIES CO·Filed 2018·Granted Mar 10, 2020·1 cites·5 claims
- 0758US11020486B2Sesame oil based injection formulations3M INNOVATIVE PROPERTIES CO·Filed 2014·Granted Jun 1, 2021·0 cites·11 claims
- 0857US2005158325A1Immunomodulatory combinations3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 0956US2021244819A1Sesame oil based injection formulations3M INNOVATIVE PROPERTIES CO·Filed 2021·Application pending·0 cites
- 1056US2018256738A1Beta-glucan compounds, compositions, and methodsBIOTHERA INC·Filed 2018·Application pending·0 cites
- 1150US2006009482A1Screening method for identifying compounds that selectively induce interferon alpha3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 1249US2005245564A1Methods and compositions related to IRM compounds and toll-like receptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 1348US2003186440A1Maturation of dendritic cells with immune response modifying compounds3M INNOVATIVE PROPERTIES CO·Filed 2003·Application pending·0 cites
- 1447US2005096259A1Neutrophil activation by immune response modifier compounds3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 1547US2015110784A1Therapeutic combinations and methods including irm compounds3M INNOVATIVE PROPERTIES CO·Filed 2014·Application pending·0 cites
- 1647US2004014779A1Methods and compositions related to IRM compounds and toll-like recptor pathways3M INNOVATIVE PROPERTIES CO·Filed 2002·Application pending·0 cites
- 1746US2005048072A1Immunostimulatory combinations and treatments3M INNOVATIVE PROPERTIES CO·Filed 2004·Application pending·0 cites
- 1846US2002110840A1Screening method for identifying compounds that selectively induce interferon alpha3M INNOVATIVE PROPERTIES CO·Filed 2001·Application pending·0 cites
- 1944US2005226878A1Therapeutic combinations and methods including IRM compounds3M INNOVATIVE PROPERTIES CO·Filed 2005·Application pending·0 cites
- 2043US8940755B2Therapeutic combinations and methods including IRM compoundsTOMAI MARK A·Filed 2004·Granted Jan 27, 2015·0 cites·13 claims
- 2143US2006142202A1Compositions and methods for targeted delivery of immune response modifiers3M INNOVATIVE PROPERTIES CO·Filed 2006·Application pending·0 cites
- 2241US2003133913A1Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules3M INNOVATIVE PROPERTIES CO·Filed 2002·Application pending·0 cites
- 2334US2012288495A1Therapeutic compositions and methodsVASILAKOS JOHN P·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Vasilakos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →